These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 30077480)
1. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015. Thompson MG; Pierse N; Sue Huang Q; Prasad N; Duque J; Claire Newbern E; Baker MG; Turner N; McArthur C; Vaccine; 2018 Sep; 36(39):5916-5925. PubMed ID: 30077480 [TBL] [Abstract][Full Text] [Related]
2. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J; Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380 [TBL] [Abstract][Full Text] [Related]
3. Influenza epidemiology and influenza vaccine effectiveness during the 2016-2017 season in the Global Influenza Hospital Surveillance Network (GIHSN). Baselga-Moreno V; Trushakova S; McNeil S; Sominina A; Nunes MC; Draganescu A; Unal S; Koul P; Kyncl J; Zhang T; Kuatbayeva A; Ben-Salah A; Burtseva E; Puig-Barberà J; Díez-Domingo J; BMC Public Health; 2019 May; 19(1):487. PubMed ID: 31046725 [TBL] [Abstract][Full Text] [Related]
6. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779 [TBL] [Abstract][Full Text] [Related]
7. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425 [TBL] [Abstract][Full Text] [Related]
8. Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). Ghamande S; Shaver C; Murthy K; Raiyani C; White HD; Lat T; Arroliga AC; Wyatt D; Talbot HK; Martin ET; Monto AS; Zimmerman RK; Middleton DB; Silveira FP; Ferdinands JM; Patel MM; Gaglani M Clin Infect Dis; 2022 Apr; 74(8):1329-1337. PubMed ID: 34320171 [TBL] [Abstract][Full Text] [Related]
9. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). Blyth CC; Macartney KK; Hewagama S; Senenayake S; Friedman ND; Simpson G; Upham J; Kotsimbos T; Kelly P; Cheng AC Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494798 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons. Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ; Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911 [TBL] [Abstract][Full Text] [Related]
11. Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15. Gherasim A; Pozo F; de Mateo S; Gamarra IA; García-Cenoz M; Vega T; Martínez E; Giménez J; Castrillejo D; Larrauri A; Vaccine; 2016 Apr; 34(20):2371-7. PubMed ID: 27020713 [TBL] [Abstract][Full Text] [Related]
12. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014. Pierse N; Kelly H; Thompson MG; Bissielo A; Radke S; Huang QS; Baker MG; Turner N; Vaccine; 2016 Jan; 34(4):503-509. PubMed ID: 26685091 [TBL] [Abstract][Full Text] [Related]
13. Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season. Mira-Iglesias A; López-Labrador FX; Baselga-Moreno V; Tortajada-Girbés M; Mollar-Maseres J; Carballido-Fernández M; Schwarz-Chavarri G; Puig-Barberà J; Díez-Domingo J; Euro Surveill; 2019 Aug; 24(31):. PubMed ID: 31387672 [TBL] [Abstract][Full Text] [Related]
15. Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network. Rondy M; Castilla J; Launay O; Costanzo S; Ezpeleta C; Galtier F; de Gaetano Donati K; Moren A Hum Vaccin Immunother; 2016 May; 12(5):1217-24. PubMed ID: 27065000 [TBL] [Abstract][Full Text] [Related]
16. Influenza Vaccine Effectiveness in Preventing Severe Outcomes in Patients Hospitalized with Laboratory-Confirmed Influenza during the 2017-2018 Season. A Retrospective Cohort Study in Catalonia (Spain). Acosta L; Soldevila N; Torner N; Martínez A; Ayneto X; Rius C; Jané M; Domínguez A; The Influenza Surveillance Network Of Catalonia Pidirac Viruses; 2021 Jul; 13(8):. PubMed ID: 34452337 [TBL] [Abstract][Full Text] [Related]
17. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. Turner N; Pierse N; Bissielo A; Huang QS; Baker MG; Widdowson MA; Kelly H; Vaccine; 2014 Jun; 32(29):3687-93. PubMed ID: 24768730 [TBL] [Abstract][Full Text] [Related]
18. Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes. Darvishian M; Dijkstra F; van Doorn E; Bijlsma MJ; Donker GA; de Lange MM; Cadenau LM; Hak E; Meijer A PLoS One; 2017; 12(1):e0169528. PubMed ID: 28068386 [TBL] [Abstract][Full Text] [Related]
19. Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015. Puig-Barberà J; Mira-Iglesias A; Tortajada-Girbés M; López-Labrador FX; Librero-López J; Díez-Domingo J; Carballido-Fernández M; Carratalá-Munuera C; Correcher-Medina P; Gil-Guillén V; Limón-Ramírez R; Mollar-Maseres J; Otero-Reigada MC; Schwarz H; Vaccine; 2017 Oct; 35(43):5799-5807. PubMed ID: 28941618 [TBL] [Abstract][Full Text] [Related]
20. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study. Casado I; Domínguez Á; Toledo D; Chamorro J; Astray J; Egurrola M; Fernández-Sierra MA; Martín V; Morales-Suárez-Varela M; Godoy P; Castilla J; CMAJ; 2018 Jan; 190(1):E3-E12. PubMed ID: 29311098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]